HUMORAL IMMUNOGENICITY AFTER VACCINATION AGAINST SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS UNDER IMMUNOSUPPRESSIVE THERAPY: SHOULD WE PRIORITIZE AN ADDITIONAL BOOSTER INJECTION?
Vítor Macedo Silva 1
Tiago Lima Capela 1
Marta Freitas 1
Tiago Cúrdia Gonçalves 1
Pedro Boal Carvalho 1
Francisca Dias de Castro 1
Maria João Moreira 1
José Berkeley Cotter 1
1 Hospital da Senhora da Oliveira, Guimarães, Portugal
Session
Covid-19 in IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]